Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX) (“Fennec” or the “Company”), a specialty pharmaceutical company, today announced the pricing of its underwritten ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback